Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

16 Dec 2023 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated December 16, 2023 titled ‘Zydus receives final approval from the USFDA for Lacosamide Tablets’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..